Studies have also shown that IL-6 is known to have a direct effect on both tumor cells and tumor inflammatory microenvironment, and is associated with several tumor types, including lymphoma, mesothelioma, lung, breast, pancreatic, colon, prostate, and stomach cancer (24–27). Here, IL6 is linked to neoplasm.